| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
22-38 |
ChemicalEntity |
denotes |
COX-2 inhibitors |
| T2 |
56-62 |
ChemicalEntity |
denotes |
NSAIDs |
| T3 |
188-215 |
DiseaseOrPhenotypicFeature |
denotes |
acute myocardial infarction |
| T4 |
217-220 |
DiseaseOrPhenotypicFeature |
denotes |
AMI |
| T5 |
227-243 |
ChemicalEntity |
denotes |
COX-2 inhibitors |
| T6 |
324-361 |
ChemicalEntity |
denotes |
non-steroidal anti-inflammatory drugs |
| T7 |
363-369 |
ChemicalEntity |
denotes |
NSAIDs |
| T8 |
425-428 |
DiseaseOrPhenotypicFeature |
denotes |
AMI |
| T9 |
433-444 |
DiseaseOrPhenotypicFeature |
denotes |
GI bleeding |
| T10 |
459-467 |
OrganismTaxon |
denotes |
patients |
| T11 |
474-490 |
ChemicalEntity |
denotes |
COX-2 inhibitors |
| T12 |
495-501 |
ChemicalEntity |
denotes |
NSAIDs |
| T13 |
506-519 |
ChemicalEntity |
denotes |
acetaminophen |
| T14 |
601-609 |
OrganismTaxon |
denotes |
patients |
| T15 |
662-667 |
ChemicalEntity |
denotes |
NSAID |
| T16 |
671-684 |
ChemicalEntity |
denotes |
acetaminophen |
| T17 |
838-845 |
ChemicalEntity |
denotes |
aspirin |
| T18 |
862-875 |
ChemicalEntity |
denotes |
acetaminophen |
| T19 |
887-896 |
ChemicalEntity |
denotes |
rofecoxib |
| T20 |
907-916 |
ChemicalEntity |
denotes |
celecoxib |
| T21 |
935-941 |
ChemicalEntity |
denotes |
NSAIDs |
| T22 |
958-965 |
ChemicalEntity |
denotes |
aspirin |
| T23 |
988-997 |
ChemicalEntity |
denotes |
rofecoxib |
| T24 |
1009-1018 |
ChemicalEntity |
denotes |
celecoxib |
| T25 |
1032-1038 |
ChemicalEntity |
denotes |
NSAIDs |
| T26 |
1053-1066 |
ChemicalEntity |
denotes |
acetaminophen |
| T27 |
1087-1094 |
ChemicalEntity |
denotes |
aspirin |
| T28 |
1172-1175 |
DiseaseOrPhenotypicFeature |
denotes |
AMI |
| T29 |
1186-1199 |
ChemicalEntity |
denotes |
acetaminophen |
| T30 |
1209-1216 |
ChemicalEntity |
denotes |
aspirin |
| T31 |
1230-1239 |
ChemicalEntity |
denotes |
rofecoxib |
| T32 |
1259-1268 |
ChemicalEntity |
denotes |
celecoxib |
| T33 |
1288-1296 |
ChemicalEntity |
denotes |
naproxen |
| T34 |
1316-1326 |
ChemicalEntity |
denotes |
diclofenac |
| T35 |
1349-1358 |
ChemicalEntity |
denotes |
ibuprofen |
| T36 |
1393-1400 |
ChemicalEntity |
denotes |
aspirin |
| T37 |
1413-1422 |
ChemicalEntity |
denotes |
rofecoxib |
| T38 |
1442-1451 |
ChemicalEntity |
denotes |
celecoxib |
| T39 |
1471-1480 |
ChemicalEntity |
denotes |
ibuprofen |
| T40 |
1500-1510 |
ChemicalEntity |
denotes |
diclofenac |
| T41 |
1530-1538 |
ChemicalEntity |
denotes |
naproxen |
| T42 |
1561-1574 |
ChemicalEntity |
denotes |
acetaminophen |
| T43 |
1625-1632 |
ChemicalEntity |
denotes |
aspirin |
| T44 |
1634-1642 |
ChemicalEntity |
denotes |
naproxen |
| T45 |
1680-1683 |
DiseaseOrPhenotypicFeature |
denotes |
AMI |
| T46 |
1684-1695 |
DiseaseOrPhenotypicFeature |
denotes |
GI bleeding |
| T47 |
1701-1704 |
DiseaseOrPhenotypicFeature |
denotes |
AMI |
| T48 |
1705-1716 |
DiseaseOrPhenotypicFeature |
denotes |
GI toxicity |
| T49 |
1720-1729 |
ChemicalEntity |
denotes |
celecoxib |
| T50 |
1753-1766 |
ChemicalEntity |
denotes |
acetaminophen |
| T51 |
1805-1814 |
ChemicalEntity |
denotes |
rofecoxib |
| T52 |
1822-1828 |
ChemicalEntity |
denotes |
NSAIDs |
| T53 |
1845-1852 |
ChemicalEntity |
denotes |
aspirin |
| T54 |
1859-1868 |
ChemicalEntity |
denotes |
celecoxib |
| T55 |
1873-1881 |
ChemicalEntity |
denotes |
naproxen |
